TY - JOUR
T1 - Increased Risk of Staphylococcus epidermidis Peritonitis in Patients on Dialysate Containing 1.25 mmol/L Calcium
AU - Piraino, Beth
AU - Bernardini, Judith
AU - Holley, Jean L.
AU - Perlmutter, Jeffrey A.
PY - 1992
Y1 - 1992
N2 - Peritoneal macrophage function is decreased in vitro in the presence of dialysate with 1.25 mmol/L calcium compared with that containing 1.75 mmol/L calcium. Theoretically, patients using this dialysate may have a higher risk of peritonitis. Nineteen patients on continuous ambulatory peritoneal dialysis (CAPD) or continuous cycling peritoneal dialysis (CCPD) were converted from dialysate with 1.75 mmol/L calcium (mean time, 33 ± 26 months) to that with 1.25 mmol/L calcium, for some or all exchanges (mean time, 10 ± 4.7 months). Peritonitis rates were compared with 19 control patients who remained on dialysate with 1.75 mmol/L calcium. The two groups were matched for the proportion of diabetics, sex, age, use of the Y-set, and dialysis modality (CAPD, CCPD). Peritonitis rates were similar in the study patients before conversion to 1.25 mmol/L calcium dialysate and in the control patients (0.49 v 0.58 episodes/patient-year, respectively). After conversion to dialysate with 1.25 mmol/L calcium, the peritonitis rate was 0.82 episodes/patient-year contrasted to 0.58 episodes/patient-year in the control patients (P = 0.09). The peritonitis rate due to Staphylococcus epidermidis was 0.51 episodes/patient-year when 1.25 mmol/L calcium dialysate was used, and 0.19 episodes/patient-year for the comparable period in the control patients on 1.75 mmol/L calcium dialysate (P = 0.005). The proportion of peritonitis episodes due to S epidermidis increased from 20% to 61% after conversion to 1.25 mmol/L calcium (P = 0.01). The increased risk of peritonitis due to S epidermidis in patients using dialysate with 1.25 mmol/L calcium is consistent with a previous study demonstrating that clearance of S epidermidis by peritoneal macrophages is less effective with a decrease in the dialysate calcium content. Further studies comparing peritonitis rates with dialysate containing 1.25 mmol/L calcium to that with 1.75 mmol/L calcium should be performed.
AB - Peritoneal macrophage function is decreased in vitro in the presence of dialysate with 1.25 mmol/L calcium compared with that containing 1.75 mmol/L calcium. Theoretically, patients using this dialysate may have a higher risk of peritonitis. Nineteen patients on continuous ambulatory peritoneal dialysis (CAPD) or continuous cycling peritoneal dialysis (CCPD) were converted from dialysate with 1.75 mmol/L calcium (mean time, 33 ± 26 months) to that with 1.25 mmol/L calcium, for some or all exchanges (mean time, 10 ± 4.7 months). Peritonitis rates were compared with 19 control patients who remained on dialysate with 1.75 mmol/L calcium. The two groups were matched for the proportion of diabetics, sex, age, use of the Y-set, and dialysis modality (CAPD, CCPD). Peritonitis rates were similar in the study patients before conversion to 1.25 mmol/L calcium dialysate and in the control patients (0.49 v 0.58 episodes/patient-year, respectively). After conversion to dialysate with 1.25 mmol/L calcium, the peritonitis rate was 0.82 episodes/patient-year contrasted to 0.58 episodes/patient-year in the control patients (P = 0.09). The peritonitis rate due to Staphylococcus epidermidis was 0.51 episodes/patient-year when 1.25 mmol/L calcium dialysate was used, and 0.19 episodes/patient-year for the comparable period in the control patients on 1.75 mmol/L calcium dialysate (P = 0.005). The proportion of peritonitis episodes due to S epidermidis increased from 20% to 61% after conversion to 1.25 mmol/L calcium (P = 0.01). The increased risk of peritonitis due to S epidermidis in patients using dialysate with 1.25 mmol/L calcium is consistent with a previous study demonstrating that clearance of S epidermidis by peritoneal macrophages is less effective with a decrease in the dialysate calcium content. Further studies comparing peritonitis rates with dialysate containing 1.25 mmol/L calcium to that with 1.75 mmol/L calcium should be performed.
KW - Peritoneal dialysis
KW - continuous ambulatory peritoneal dialysis
KW - peritonitis
UR - http://www.scopus.com/inward/record.url?scp=0026590067&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0026590067&partnerID=8YFLogxK
U2 - 10.1016/S0272-6386(12)80456-2
DO - 10.1016/S0272-6386(12)80456-2
M3 - Article
C2 - 1562027
AN - SCOPUS:0026590067
SN - 0272-6386
VL - 19
SP - 371
EP - 374
JO - American Journal of Kidney Diseases
JF - American Journal of Kidney Diseases
IS - 4
ER -